{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:43:56Z","timestamp":1790099036410,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.cgh.2013.08.024","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T17:00:47Z","timestamp":1377363647000},"page":"32-44.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review"],"prefix":"10.1016","volume":"12","author":[{"given":"John","family":"Melek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.08.024_bib1","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1572-0241.1999.01079.x","article-title":"Evolution of osteopenia in inflammatory bowel disease","volume":"94","author":"Dinca","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.08.024_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0169-6009(08)80046-3","article-title":"A\u00a0four-year longitudinal study of bone loss in patients with inflammatory bowel disease","volume":"23","author":"Motley","year":"1993","journal-title":"Bone Miner"},{"key":"10.1016\/j.cgh.2013.08.024_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/gut.37.1.71","article-title":"A\u00a0controlled study of bone mineral density in patients with inflammatory bowel disease","volume":"37","author":"Silvennoinen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.08.024_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2003.09.027","article-title":"Inflammatory bowel disease and the risk of fracture","volume":"125","author":"van Staa","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","article-title":"AGA technical review on osteoporosis in gastrointestinal diseases","volume":"124","author":"Bernstein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib7","first-page":"1","article-title":"Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease","volume":"14","author":"Lewis","year":"2007","journal-title":"British Society of Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0016-5085(95)90068-3","article-title":"Metabolic bone assessment in patients with inflammatory bowel disease","volume":"108","author":"Abitbol","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.08.024_bib10","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2013.08.024_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of bisphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russell","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.cgh.2013.08.024_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2036.1996.63205000.x","article-title":"A\u00a0randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study","volume":"10","author":"Bernstein","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.08.024_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2036.2008.03899.x","article-title":"Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis","volume":"29","author":"Kitazaki","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.08.024_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ajg.2011.59","article-title":"A\u00a0single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial","volume":"106","author":"Klaus","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.08.024_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2013.08.024_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib17","series-title":"Advances in meta-analysis","author":"Pigott","year":"2012"},{"key":"10.1016\/j.cgh.2013.08.024_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2013.08.024_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2013.08.024_bib20","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration,\u00a02011."},{"key":"10.1016\/j.cgh.2013.08.024_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MPG.0b013e3180dca0cc","article-title":"Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease","volume":"45","author":"Benchimol","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2013.08.024_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/gast.2000.16518","article-title":"Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease","volume":"119","author":"Haderslev","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2003.01794.x","article-title":"A\u00a0randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease","volume":"18","author":"Bartram","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.08.024_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2036.2003.01448.x","article-title":"Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate","volume":"17","author":"von Tirpitz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.08.024_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-005-1927-z","article-title":"Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease","volume":"16","author":"Palomba","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1542-3565(04)00663-9","article-title":"Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease","volume":"3","author":"Siffledeen","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.08.024_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.2006.00372.x","article-title":"A\u00a0double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease","volume":"101","author":"Henderson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.08.024_bib28","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cgh.2007.05.016","article-title":"A\u00a0double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease","volume":"5","author":"Abitbol","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.08.024_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00198-009-0960-8","article-title":"Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease","volume":"21","author":"Kriel","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1442-200X.2010.03174.x","article-title":"Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease","volume":"52","author":"Sbrocchi","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3748\/wjg.v17.i3.334","article-title":"Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D","volume":"17","author":"Klaus","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.08.024_bib32","first-page":"141","article-title":"Intravenous ibandronate or sodium-fluoride: a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis","volume":"20","author":"Klaus","year":"2011","journal-title":"J\u00a0Gastrointest Liver Dis"},{"key":"10.1016\/j.cgh.2013.08.024_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.2002.01247.x","article-title":"Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride","volume":"16","author":"Abitbol","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.08.024_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00042737-200012010-00005","article-title":"Increase of bone mineral density with sodium fluoride in patients with Crohn's disease","volume":"12","author":"von Tirpitz","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.08.024_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s001980070051","article-title":"Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis","volume":"11","author":"Haguenauer","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2011.129","article-title":"Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial","volume":"106","author":"Pappa","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.08.024_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(98)70362-2","article-title":"Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial","volume":"115","author":"Robinson","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.08.024_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/er.2001-7002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis: VII\u2014meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis","volume":"23","author":"Shea","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cgh.2013.08.024_bib40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/er.2001-8002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis: VIII\u2014meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women","volume":"23","author":"Papadimitropoulos","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cgh.2013.08.024_bib41","first-page":"CD000227","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis","author":"Gillespie","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2013.08.024_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00002018-200528080-00006","article-title":"Benefit-risk assessment of raloxifene in postmenopausal osteoporosis","volume":"28","author":"Cranney","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2013.08.024_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s001980070096","article-title":"The long-term effectiveness of preventive strategies for osteoporosis in postmenopausal women: a modeling approach","volume":"11","author":"Le Pen","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib45","first-page":"41","article-title":"Corticosteroid-induced osteoporosis","volume":"313","author":"Adachi","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2013.08.024_bib46","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","article-title":"Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial","volume":"157","author":"Ensrud","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/gut.34.11.1543","article-title":"Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease","volume":"34","author":"Clements","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.08.024_bib48","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2013.08.024_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-123-6-199509150-00001","article-title":"Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial","volume":"123","author":"Pak","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib50","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/archinte.161.19.2325","article-title":"Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis","volume":"161","author":"Rubin","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A\u00a0randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study\u2014PROOF Study Group","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib52","first-page":"CD001983","article-title":"Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis","author":"Cranney","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2013.08.024_bib53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/er.2001-6002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis: VI\u2014meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cgh.2013.08.024_bib54","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02565124","article-title":"Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients","volume":"49","author":"Montemurro","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.cgh.2013.08.024_bib56","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-155-12-201112200-00005","article-title":"Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force","volume":"155","author":"Chung","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2013.08.024_bib58","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513012263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513012263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:13:21Z","timestamp":1761542001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356513012263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1542356513012263"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.08.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718087914.793484311","asserted-by":"object"}]},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}